Duncan Pharma
Well-Known Member
GLP-1 subdues total glucagon secretion from pancreatic alpha cells when sugar levels are elevated. Furthermore, GLP-1 promotes satiation as well as decrease gastric emptying, as well as their usage, is connected with weight reduction
GLP-1 agonists promote glucose-insulin secretion, slow gastric motility and reduce the levels of glucagon following meals, which results in a hypoglycaemic effect even following intravenous administration, without hypoglycaemia
Research use only. Not for human or animal consumption!
STARTING DOSE: You inject 3ml water into the vial of GLP-1 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in color you draw out 0.75 (3 quarters of syringe) once a week in the morning before breakfast and inject it into the tummy under the skin into the fatty skin layer. A vial should last 4 weeks.
MAINTENANCE DOSE: You inject 1ml water into the vial of GLP-1 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in color you draw out the entire vial once a week in the morning before breakfast and inject it into the tummy under the skin into the fatty skin layer. A vial should last 1 week.
Nausea
Vomiting
Diarrhea
Low blood sugar levels (hypoglycemia) are a more serious risk linked to the GLP-1 class of medications. But the risk of low blood sugar levels is usually only increased if you're taking another medication known to lower blood sugar at the same time, such as sulfonylureas or insulin.
Lyophilized
Storage Conditions
20 °C Protected from light
GLP-1 agonists promote glucose-insulin secretion, slow gastric motility and reduce the levels of glucagon following meals, which results in a hypoglycaemic effect even following intravenous administration, without hypoglycaemia
Research use only. Not for human or animal consumption!
Dosage:
Mixing and our recommended dosageSTARTING DOSE: You inject 3ml water into the vial of GLP-1 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in color you draw out 0.75 (3 quarters of syringe) once a week in the morning before breakfast and inject it into the tummy under the skin into the fatty skin layer. A vial should last 4 weeks.
MAINTENANCE DOSE: You inject 1ml water into the vial of GLP-1 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in color you draw out the entire vial once a week in the morning before breakfast and inject it into the tummy under the skin into the fatty skin layer. A vial should last 1 week.
Side effects:
Some of the more common side effects include:Nausea
Vomiting
Diarrhea
Low blood sugar levels (hypoglycemia) are a more serious risk linked to the GLP-1 class of medications. But the risk of low blood sugar levels is usually only increased if you're taking another medication known to lower blood sugar at the same time, such as sulfonylureas or insulin.
Composition:
FormLyophilized
Storage Conditions
20 °C Protected from light
